Free Trial

Electromed (ELMD) Competitors

Electromed logo
$18.24 -1.06 (-5.49%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$18.23 -0.01 (-0.03%)
As of 08:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. CBLL, EMBC, BBNX, BVS, AVNS, RXST, AXGN, KIDS, BFLY, and SMLR

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), Bioventus (BVS), Avanos Medical (AVNS), RxSight (RXST), AxoGen (AXGN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Electromed vs. Its Competitors

Electromed (NYSE:ELMD) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Electromed presently has a consensus price target of $38.00, suggesting a potential upside of 108.33%. CeriBell has a consensus price target of $32.14, suggesting a potential upside of 104.34%. Given Electromed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Electromed is more favorable than CeriBell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
CeriBell
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

Electromed has a net margin of 11.34% compared to CeriBell's net margin of 0.00%. Electromed's return on equity of 15.71% beat CeriBell's return on equity.

Company Net Margins Return on Equity Return on Assets
Electromed11.34% 15.71% 13.37%
CeriBell N/A N/A N/A

In the previous week, CeriBell had 9 more articles in the media than Electromed. MarketBeat recorded 9 mentions for CeriBell and 0 mentions for Electromed. CeriBell's average media sentiment score of 0.53 beat Electromed's score of 0.00 indicating that CeriBell is being referred to more favorably in the news media.

Company Overall Sentiment
Electromed Neutral
CeriBell Positive

Electromed has higher earnings, but lower revenue than CeriBell.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electromed$61.44M2.49$5.15M$0.7923.09
CeriBell$65.44M8.69-$40.46MN/AN/A

40.8% of Electromed shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Comparatively, 20.1% of CeriBell shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Electromed beats CeriBell on 8 of the 14 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$152.96M$35.10M$5.61B$20.82B
Dividend YieldN/AN/A4.23%3.65%
P/E Ratio24.323.0928.5427.17
Price / Sales2.49233.75430.1147.97
Price / Cash41.3641.3636.0222.28
Price / Book3.581.978.144.56
Net Income$5.15M-$2.66M$3.24B$995.22M
7 Day Performance-11.07%-5.90%0.17%-1.16%
1 Month Performance-9.34%23.43%5.95%3.18%
1 Year Performance18.90%113.91%26.22%6.83%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
0.8626 of 5 stars
$18.24
-5.5%
$38.00
+108.3%
+20.2%$152.96M$61.44M24.32160
CBLL
CeriBell
2.6078 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$621.61M$65.44M0.00N/A
EMBC
Embecta
4.7532 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-25.4%$586.15M$1.12B11.142,100News Coverage
Positive News
BBNX
Beta Bionics
N/A$13.40
-0.9%
$23.44
+75.0%
N/A$580.97M$69.83M0.00294
BVS
Bioventus
2.7105 of 5 stars
$6.82
-2.8%
$13.75
+101.6%
-4.3%$560.22M$567.70M-11.181,200
AVNS
Avanos Medical
2.8803 of 5 stars
$11.87
-3.9%
N/A-44.8%$548.87M$687.80M-1.422,227News Coverage
Negative News
RXST
RxSight
2.2241 of 5 stars
$12.43
-4.8%
$37.90
+204.9%
-84.7%$530.31M$148.31M-18.55220Analyst Downgrade
AXGN
AxoGen
2.3019 of 5 stars
$11.36
+3.9%
$24.50
+115.7%
+34.8%$517.33M$187.34M-75.73450News Coverage
Analyst Revision
High Trading Volume
KIDS
OrthoPediatrics
4.2641 of 5 stars
$21.24
-5.5%
$35.83
+68.7%
-33.1%$515.92M$204.73M-12.14200Analyst Forecast
BFLY
Butterfly Network
2.3862 of 5 stars
$1.89
-2.6%
$3.50
+85.2%
+47.5%$467.38M$85.63M-6.52460
SMLR
Semler Scientific
2.5925 of 5 stars
$38.95
-3.7%
$71.00
+82.3%
+21.4%$434.29M$56.29M-14.92120

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners